WHITNEY BONSER: Open Payments
NPI 1861146474 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,071 in 51 payments from 18 companies in 2025. Trend: 2023 $1,391 · 2024 $1,700 · 2025 $1,071
Food & beverage: $1,071Education: $0
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 8 | $157 |
| Amgen Inc. | 9 | $138 |
| OPKO Pharmaceuticals, LLC | 5 | $105 |
| Travere Therapeutics, Inc. | 5 | $104 |
| Calliditas Therapeutics US Inc. | 3 | $86 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $57 |
| Alexion Pharmaceuticals, Inc. | 2 | $46 |
| ANI Pharmaceuticals, Inc. | 2 | $44 |
| Renalytix AI, Inc. | 2 | $41 |
Products named: ACTHAR, RAYALDEE, KRYSTEXXA, TARPEYO, JARDIANCE, Kerendia, ULTOMIRIS, PURIFIED CORTROPHIN GEL.
Industry payments across TX — which companies pay providers there.
